~~<i id='DAA9C57F85'><strike id='DAA9C57F85'><tt id='DAA9C57F85'><pre id='DAA9C57F85'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

Wikipedia

author：Wikipedia 2025-08-25 06:01:29 - browse：62

Alkermes shareholders voted Thursday to re-elect all of the drugmaker’s current directors, ending an acrimonious proxy fight with hedge fund Sarissa Capital Management, which had sought to seat three directors on the board.

At the company’s annual meeting, shareholders voted in favor of Alkermes’ proposal to retain all seven of the director nominees to the 11-person board.

The outcome is a setback for Sarissa, which owns 8.5% of Alkermes and is run by activist investor Alex Denner. Sarissa has accused Alkermes executives of mismanaging the business and destroying shareholder value.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Readout LOUD podcast: How biotech is using artificial intelligence

hotspot

leisure time

focus

explore

focus

explore

RobertF.KennedyJr.talkswithreportersinthelobbyofTrumpTowerin2017.EvanVucci/APYou’rereadingthewebedit

WSS

Maui wildfire now ranks as the fifth

Illumina slashes 2023 revenue projections yet again

Dozens dead from Maui wildfires: What we know about the victims

Timeline: How the deadly wildfires took over Maui day by day

After Optum profits sink, UnitedHealth makes changes

Private equity deals in Medicare Advantage declines

leisure time

Wikipedia

hotspot

After affirmative action ruling, medical educators look to 'holistic review'

Biogen’s boardroom scandal saddles CEO with first crisis

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Biogen’s boardroom scandal saddles CEO with first crisis

Medical records are filled with copy

Hospitals are dialing back on venture capital investing

Medicare details structure of new drug price negotiation program

Mark Cuban is blaming the wrong people for high drug costs

Guidelines to prevent youth baseball injuries need more muscle

Senators push IRS to launch nonprofit hospital probe

leisure time

Health AI: on the border between health care and tech

Readout LOUD podcast: How biotech is using artificial intelligence

Illinois Supreme Court finds assault weapons ban constitutional

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

Doctors' information doesn't help them choose wisely when sick

What should King Charles tell the public about his cancer?

focus

explore

focus

explore